基本信息
浏览量:436
职业迁徙
个人简介
The Department of Hepatobiliary and Pancreatic Oncology treats tumors originating from the liver, biliary system or pancreas, which include hepatocellular carcinoma (HCC), biliary tract cancer, pancreatic cancer, and neuroendocrine tumor (NET)/carcinoma (NEC). As part of the multidisciplinary care given at the National Cancer Center Hospital (NCCH), the team works closely with surgeons, radiologists, psychologists, and others who have special expertise in these areas. The team also conducts early- to late-phase clinical trials and translational research and seeks to develop new and more effective diagnostic methods and treatments. The department keeps providing best and latest diagnosis, treatment and supportive care, and developing their more effective methods and techniques for all patients with hepatobiliary and pancreatic cancer in this country and worldwide. Among them, conducting clinical trials with novel promising agents for this disease is considered one of the most important tasks, and establishment of cutting-edge medical treatments in this field is the most significant mission for us.
研究兴趣
论文共 754 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Soma Fukuda,Susumu Hijioka,Yoshikuni Nagashio,Yuta Maruki,Akihiro Ohba, Daiki Agarie,Yuya Hagiwara,Hidenobu Hara,Kohei Okamoto,Daiki Yamashige, Shin Yagi, Masaru Kuwada,
Endoscopy International Open (2024)
Daiki Yamashige,Susumu Hijioka,Yoshikuni Nagashio,Yuta Maruki, Soma Fukuda, Shin Yagi,Kohei Okamoto,Hidenobu Hara,Yuya Hagiwara, Daiki Agarie,Tetsuro Takasaki, Mark Chatto,
Endoscopy International Openno. 3 (2024): E367-E376
Journal of the National Comprehensive Cancer Network : JNCCNno. 2.5 (2024)
Mashio Nakamura,Masato Sakon, Mitsuru Sasako,Takuji Okusaka,Hirofumi Mukai,Keiichi Fujiwara,Hideo Kunitoh,Mari S. Oba,Hideo Wada, Jun Hosokawa,Atsushi Takita,Masataka Ikeda
International Journal of Clinical Oncologyno. 4 (2024): 407-416
ONCOLOGISTno. 1 (2024): e97-e107
Endoscopyno. S 01 (2024): E366-E368
ANTICANCER RESEARCHno. 2 (2024): 533-542
Anticancer researchno. 2 (2024): 533-542
EJSOno. 1 (2024): 107324-107324
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn